tachycardia
Conditions
Interventions
Pre close
Post close
Sponsors
Toyama Prefectural Central Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: participants included patients who were over 20 years old who underwent elective, nonemergent, catheter ablation via the common femoral veins using a 6-F to 13F inner diameter introducer sheath, a minimum of 2 and maximum of 4 femoral venous access sites, and a maximum of 3 access sites per leg were enrolled.
Exclusion criteria
Exclusion criteria: Exclusion criteria included vascular surgery or catheter ablation within the last three months, active systemic or cutaneous infection or inflammation in the vicinity of the groin, any preexisting immunodeficiency disorder, long term use of high dose systemic steroids, history of bleeding diathesis, coagulopathy, hypercoagulability, or thromboembolic events, platelet count over 100,000 cells per mm, or severe comorbidities with life expectancy 12 months in the opinion of the site investigator. After providing informed consent, patients underwent the appropriate ablation procedure
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary efficacy endpoint was rebleeding rate requiring recompression during immobilization, bedrest and after ambulation. The primary safety endpoint is the incidence of major complications related to venous access site closure at 90days. | — |
Countries
Japan
Contacts
Public ContactAkio Chikata
Toyama Prefectural Central Hospital Department of Cardiology
Outcome results
None listed